BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35339566)

  • 61. Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients.
    Lin P; Bueso-Ramos C; Wilson CS; Mansoor A; Medeiros LJ
    Am J Surg Pathol; 2003 Aug; 27(8):1104-13. PubMed ID: 12883242
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Endomyocardial biopsy with co-localization of a lymphoplasmacytic lymphoma and AL amyloidosis.
    Leguit RJ; Vink A; de Jonge N; Minnema MC; Oerlemans MIF
    Cardiovasc Pathol; 2021; 53():107348. PubMed ID: 34038803
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Burnworth B; Wang Z; Singleton TP; Bennington A; Fritschle W; Bennington R; Brodersen LE; Wells DA; Loken MR; Zehentner BK
    Leuk Res; 2016 Dec; 51():41-48. PubMed ID: 27890075
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.
    Traverse-Glehen A; Bachy E; Baseggio L; Callet-Bauchu E; Gazzo S; Verney A; Hayette S; Jallades L; Ffrench M; Salles G; Coiffier B; Felman P; Berger F
    Histopathology; 2013 May; 62(6):876-93. PubMed ID: 23611359
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Waldenström Macroglobulinemia and Non-IgM-Type Lymphoplasmacytic Lymphoma Are Genetically Similar.
    Awata-Shiraiwa M; Yokohama A; Kanai Y; Gotoh N; Kasamatsu T; Handa H; Saitoh T; Murakami H; Hirato J; Ikota H; Tsukamoto N
    Acta Haematol; 2023; 146(5):384-390. PubMed ID: 36917966
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform.
    Zhang W; Ao Q; Guan Y; Zhu Z; Kuang D; Li MMQ; Shen K; Zhang M; Wang J; Yang L; Cai H; Wang Y; Young KH; Zhou J; Xiao M
    Mod Pathol; 2022 May; 35(5):632-639. PubMed ID: 34802044
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
    Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
    Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The pathology and genetic background of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia].
    Timár B
    Magy Onkol; 2017 Mar; 61(1):6-11. PubMed ID: 28273183
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis.
    Rossi D
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):113-8. PubMed ID: 25696843
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation.
    Brunner A; Thalhammer-Thurner GC; Willenbacher W; Haun M; Zelger BG; Willenbacher E
    Ann Hematol; 2024 Feb; 103(2):553-563. PubMed ID: 37951851
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lymphoplasmacytic lymphoma and marginal zone lymphoma involving bone marrow: A diagnostic dilemma. Useful clinicopathological features to accurate the diagnosis.
    García-Abellás P; Ferrer Gómez A; Bueno Sacristán D; Piris Villaespesa M; Talavera Yagüe M; Reguero Callejas ME; García-Cosío M
    EJHaem; 2022 Nov; 3(4):1181-1187. PubMed ID: 36467836
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
    Ishiguro K; Sasaki Y; Takagi Y; Niinuma T; Suzuki H; Tokino T; Hayashi T; Takahashi T; Igarashi T; Matsuno Y
    Medicine (Baltimore); 2020 Aug; 99(35):e21938. PubMed ID: 32871937
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma.
    Baloda V; Wheeler SE; Murray DL; Kohlhagen MC; Vos JA; Yatsenko SA; Agha ME; Djokic M; Swerdlow SH; Bailey NG
    Diagn Pathol; 2022 Aug; 17(1):63. PubMed ID: 35932039
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lymphoplasmacytic Lymphoma Presenting with Diarrhea and Joint Pain Which was Successfully Diagnosed by an MYD88 Mutation Analysis.
    Fukushima M; Okoshi Y; Fukazawa K; Koshino M; Ishiguro S; Mitsuhashi S; Saitoh H; Iijima T; Kojima H; Hori M
    Intern Med; 2017; 56(7):847-851. PubMed ID: 28381754
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Highly sensitive
    Drandi D; Genuardi E; Dogliotti I; Ferrante M; Jiménez C; Guerrini F; Schirico ML; Mantoan B; Muccio V; Lia G; Zaccaria GM; Omedè P; Passera R; Orsucci L; Benevolo G; Cavallo F; Galimberti S; Sanz RG; Boccadoro M; Ladetto M; Ferrero S
    Haematologica; 2018 Jun; 103(6):1029-1037. PubMed ID: 29567768
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exome sequencing identifies recurrent
    Jallades L; Baseggio L; Sujobert P; Huet S; Chabane K; Callet-Bauchu E; Verney A; Hayette S; Desvignes JP; Salgado D; Levy N; Béroud C; Felman P; Berger F; Magaud JP; Genestier L; Salles G; Traverse-Glehen A
    Haematologica; 2017 Oct; 102(10):1758-1766. PubMed ID: 28751561
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic and phenotypic attributes of splenic marginal zone lymphoma.
    Bonfiglio F; Bruscaggin A; Guidetti F; Terzi di Bergamo L; Faderl M; Spina V; Condoluci A; Bonomini L; Forestieri G; Koch R; Piffaretti D; Pini K; Pirosa MC; Cittone MG; Arribas A; Lucioni M; Ghilardi G; Wu W; Arcaini L; Baptista MJ; Bastidas G; Bea S; Boldorini R; Broccoli A; Buehler MM; Canzonieri V; Cascione L; Ceriani L; Cogliatti S; Corradini P; Derenzini E; Devizzi L; Dietrich S; Elia AR; Facchetti F; Gaidano G; Garcia JF; Gerber B; Ghia P; Gomes da Silva M; Gritti G; Guidetti A; Hitz F; Inghirami G; Ladetto M; Lopez-Guillermo A; Lucchini E; Maiorana A; Marasca R; Matutes E; Meignin V; Merli M; Moccia A; Mollejo M; Montalban C; Novak U; Oscier DG; Passamonti F; Piazza F; Pizzolitto S; Rambaldi A; Sabattini E; Salles G; Santambrogio E; Scarfò L; Stathis A; Stüssi G; Geyer JT; Tapia G; Tarella C; Thieblemont C; Tousseyn T; Tucci A; Vanini G; Visco C; Vitolo U; Walewska R; Zaja F; Zenz T; Zinzani PL; Khiabanian H; Calcinotto A; Bertoni F; Bhagat G; Campo E; De Leval L; Dirnhofer S; Pileri SA; Piris MA; Traverse-Glehen A; Tzankov A; Paulli M; Ponzoni M; Mazzucchelli L; Cavalli F; Zucca E; Rossi D
    Blood; 2022 Feb; 139(5):732-747. PubMed ID: 34653238
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MALT lymphoma with IgM paraprotein and bone marrow involvement mimicking Waldenström macroglobulinaemia.
    Wang SC; Huang WT; Ma MC; Medeiros LJ; Chang KC
    Pathology; 2019 Aug; 51(5):549-553. PubMed ID: 31202483
    [No Abstract]   [Full Text] [Related]  

  • 79. Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma.
    Randen U; Trøen G; Tierens A; Steen C; Warsame A; Beiske K; Tjønnfjord GE; Berentsen S; Delabie J
    Haematologica; 2014 Mar; 99(3):497-504. PubMed ID: 24143001
    [TBL] [Abstract][Full Text] [Related]  

  • 80. IRTA1 and MNDA Expression in Marginal Zone Lymphoma: Utility in Differential Diagnosis and Implications for Classification.
    Wang Z; Cook JR
    Am J Clin Pathol; 2019 Feb; 151(3):337-343. PubMed ID: 30346478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.